title: Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases - author's reply.
authors.affiliation: Massachusetts General Hospital Crohn's and Colitis Center, Boston, MA, USA. aananthakrishnan@mgh.harvard.edu.
authors.forename: A N
authors.initials: AN
authors.lastname: Ananthakrishnan
mesh_terms: D003920:Diabetes Mellitus / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male
chemical_list: D007155:Immunologic Factors